Antibody Analytics
RoukenBio (formerly Antibody Analytics) is a Glasgow-based preclinical immunology CRO providing antibody, cell therapy, and immune cell assay services to global biotech clients across 25 countries.
- Company typePrivate
- Founded2015
- HeadquartersGlasgow, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Antibody Analytics does
RoukenBio (formerly Antibody Analytics) is a Glasgow-based preclinical contract research organization founded in 2015 that provides immunology-focused drug development services to global biotechnology and pharmaceutical clients. The company operates a discovery CRO model covering the full spectrum from early drug discovery through pre-IND testing, with particular depth in therapeutic antibody development, cell therapy approaches (including ex-vivo and in-vivo solid tumor work), and immune cell-based functional assays. Its core service offering spans three solution pillars: phase-based support across the drug development lifecycle, therapeutic modality expertise (small molecule, large molecule, and advanced therapeutics), and therapeutic-area specialization.
Antibody Analytics firmographics
Firmographics- Name
- Antibody Analytics
- Legal name
- RoukenBio
- Website
- https://antibodyanalytics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RoukenBio (formerly Antibody Analytics) is a Glasgow-based preclinical immunology CRO providing antibody, cell therapy, and immune cell assay services to global biotech clients across 25 countries.
- Ownership category
- akta.pro rank
Antibody Analytics industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Antibody Analytics is headquartered
LocationHeadquarters
- HQ city
- Glasgow
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Antibody Analytics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Research Services: Discovery CRO providing drug development services to support global customer base in developing small molecule, large molecule and advanced therapeutics from early discovery through clinical phases. Services are project-based and collaborative research engagements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Antibody Analytics product offering
Product offeringCore offering
Antibody Analytics (now operating as RoukenBio) is a preclinical contract research organisation (CRO) specialised in immunology, providing drug development services to biotechnology companies from early discovery through pre-IND testing. The company delivers ex vivo primary cell assays, immune cell-based functional assays, and bespoke assay design across small molecules, large molecules, and advanced therapeutics including antibody therapeutics and cell therapies. Its RoukenCells sub-brand offers assay-ready INDEX-2 cell lines, reporter cells, and immune cell banks as standalone cellular tools for modern therapeutic development.
Product overview
RoukenBio is a discovery Contract Research Organisation (CRO) offering a unified platform of preclinical immunology services. The company provides an integrated portfolio spanning Phase support (early discovery through clinical phases), therapeutic modality development services, and specialized assay capabilities. The RoukenCells sub-brand provides proven cellular tools including assay-ready cell lines, reporter cells, and immune cell banks. The overall offering combines assay development, service areas, scientific resources (whitepapers, research posters, webinars), and state-of-the-art equipment to support drug discovery from early phases through pre-IND testing.
Differentiator
Problem solved
Functional benefit
Brands
- RoukenCells: Cellular tools including assay-ready index-2 cell lines, reporter cells and immune cell banks for modern therapeutic development.
Products and services
- RoukenCells Assay-ready cellular tools including INDEX-2 cell lines, reporter cells, and immune cell banks designed for modern therapeutic development and offered to researchers developing biotherapeutics.
- Preclinical Immunology CRO Services
Quantifiable outcome
- Net Promoter Score of 79 - clients highly value working with RoukenBio
- +4 more outcomes
Companies that use Antibody Analytics
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Antibody Analytics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Antibody Analytics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AVS BiocoreRoukenBio and AVS Bio formed a strategic partnership to strengthen therapeutic antibody development through integrated functional biology and discovery expertise. This partnership combines RoukenBio's immunology assay capabilities with AVS Bio's discovery expertise to provide comprehensive support for therapeutic antibody development programs.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Antibody Analytics competitors and assessment
Company assessmentDirect peers
- ProImmune: UK-based specialist immunology CRO offering immune monitoring, antibody characterization, and cell-based assays. Closely comparable in being a niche immunology-focused CRO supporting therapeutic antibody and biologics development.
- CellCarta: Specialty immunology and histopathology-focused CRO supporting immuno-oncology and cell therapy development. Direct peer in delivering complex immune cell-based assays and biomarker work to biotech and pharma preclinical pipelines.
- Reaction Biology: Specialized preclinical CRO offering a broad catalog of biology and immunology assays, including antibody and cell-based services for therapeutic discovery. Comparable in scale and positioning as a specialist supporting biotech preclinical workflows.
Emerging players
- AbCellera: Antibody discovery platform combining single-cell screening with downstream functional characterization. Tangentially competes where clients choose integrated antibody discovery plus functional evaluation, encroaching on the niche assay work RoukenBio performs.
- Arctoris: Technology-enabled preclinical discovery CRO offering automated assay services for small molecule and biologics programs. Emerging competitor for outsourced preclinical work where clients weigh specialist scientific depth versus platform-driven throughput.
Broad incumbents
- Charles River Laboratories: Global CRO with significant discovery and safety assessment services including immunology and biologics capabilities. Competes for large-molecule preclinical programs and represents the incumbent scale alternative to specialist players like RoukenBio.
- Labcorp (Covance): Diversified CRO and central laboratory services provider with extensive preclinical and clinical assay capabilities. Overlaps with RoukenBio in cell-based immunology and antibody characterization work delivered through an integrated, global platform.
- GenScript: Global life sciences services company offering antibody development, cell therapy, and biologics discovery services. Comparable in the cell-therapy and antibody functional assay segments addressed by RoukenBio, at a significantly larger global scale.
- Eurofins Discovery: Discovery services arm of Eurofins offering preclinical assay, pharmacology, and immunology capabilities across small and large molecules. Overlaps directly with RoukenBio in antibody and immune cell-based functional assays, but as part of a much broader service portfolio.
Others
- Bio-Techne: Reagent and assay kit provider including immune cell lines, cytokines, and assay reagents. Adjacent via the RoukenCells-style reagent opportunity and as a supplier/adjacent ecosystem participant in antibody and immunology workflows.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Antibody Analytics social profiles
Digital presenceAntibody Analytics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Antibody Analytics leadership team
Management profileNumber of profiles
Profiles1 record
Antibody Analytics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Antibody Analytics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Antibody Analytics
What does Antibody Analytics do?
Antibody Analytics (now operating as RoukenBio) is a preclinical contract research organisation (CRO) specialised in immunology, providing drug development services to biotechnology companies from early discovery through pre-IND testing. The company delivers ex vivo primary cell assays, immune cell-based functional assays, and bespoke assay design across small molecules, large molecules, and advanced therapeutics including antibody therapeutics and cell therapies. Its RoukenCells sub-brand offers assay-ready INDEX-2 cell lines, reporter cells, and immune cell banks as standalone cellular tools for modern therapeutic development.
Is Antibody Analytics a public or private company?
Antibody Analytics is a private company. It is classified as private equity controlled and is currently operating.
When was Antibody Analytics founded?
Antibody Analytics was founded in 2015. It employs 51 to 100 people.
Where is Antibody Analytics based?
Antibody Analytics is headquartered in Glasgow, United Kingdom, in the Europe region.
How does Antibody Analytics make money?
One revenue line is on record: contract Research Services.
Who are Antibody Analytics's main competitors?
Direct peers on record are ProImmune, CellCarta and Reaction Biology. Emerging players are AbCellera and Arctoris. Broad incumbents are Charles River Laboratories, Labcorp (Covance), GenScript and Eurofins Discovery. Bio-Techne is listed as an others.
Does Antibody Analytics have an API?
No public API is recorded for Antibody Analytics.
What industry is Antibody Analytics in?
Antibody Analytics's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541714 and its SIC code is 8731.